NuScale Power Shares Surge Amid Conflicting Analyst Views

NuScale Power Corporation witnessed a substantial rally in its share price during yesterday’s trading session, with the stock climbing 7.7% to close at $39.45. This upward movement was supported by exceptionally high trading activity, as approximately 18.6 million shares changed hands—a figure that exceeded the daily average volume by 49%. Multiple catalysts contributed to this bullish investor sentiment.

Regulatory Hurdle Cleared

A significant factor behind the positive momentum was the passing of an October 1st deadline related to a tripartite agreement involving the U.S. Department of Energy. The $32.3 million contract for reactor components faced potential termination if not finalized by this date. Market participants interpreted the absence of negative announcements following the deadline as confirmation that the agreement remains intact, allowing NuScale to retain these valuable assets.

Diverging Analyst Perspectives

The investment community remains sharply divided on NuScale’s prospects. This division became particularly evident as major financial institutions issued contradictory recommendations. Barclays initiated coverage with an “Equal Weight” rating and established a price target of $45 per share. Conversely, BofA Securities adopted a bearish stance, downgrading the stock from “Neutral” to “Underperform” while simultaneously reducing their price objective from $38 to $34. These opposing viewpoints highlight the substantial volatility surrounding the nuclear technology specialist.

Should investors sell immediately? Or is it worth buying Nuscale Power?

Insider Transactions Amid Market Optimism

Recent SEC filings revealed substantial selling activity by company insiders. On October 1st, a director associated with Fluor Corp disposed of shares valued at over $19.4 million. Additionally, major shareholder Fluor Corporation decreased its holdings in late September. Typically, such significant insider selling would exert downward pressure on a stock’s valuation. However, in this instance, positive developments appear to have overshadowed these transactions in investors’ minds.

Financial Performance and Future Expectations

The company’s most recent earnings report from August presented disappointing results, showing a loss of $0.13 per share on revenue of $8.05 million. The analyst consensus currently maintains a “Hold” recommendation with an average price target of $36.67. The true test for NuScale’s recent surge will come on November 6th, when the company releases its next quarterly results. These figures will need to substantiate the current market optimism to sustain the positive momentum.